Are Dose-Dense and Triplet Chemotherapy Regimens Optimal Adjuvant Therapy in the Majority of Women With Node-Positive Early Breast Cancer?

MLA

Eugene Moylan, et al. “Are Dose-Dense and Triplet Chemotherapy Regimens Optimal Adjuvant Therapy in the Majority of Women With Node-Positive Early Breast Cancer?” Journal of Clinical Oncology, vol. 32, Feb. 2014, pp. 605–06. EBSCOhost, https://doi.org/10.1200/jco.2013.53.6771.

APA

Eugene Moylan, Louise C. Connell, & Seamus O’Reilly. (2014). Are Dose-Dense and Triplet Chemotherapy Regimens Optimal Adjuvant Therapy in the Majority of Women With Node-Positive Early Breast Cancer? Journal of Clinical Oncology, 32, 605–606. https://doi.org/10.1200/jco.2013.53.6771

Chicago

Eugene Moylan, Louise C. Connell, and Seamus O’Reilly. 2014. “Are Dose-Dense and Triplet Chemotherapy Regimens Optimal Adjuvant Therapy in the Majority of Women With Node-Positive Early Breast Cancer?” Journal of Clinical Oncology 32 (February): 605–6. doi:10.1200/jco.2013.53.6771.